Women with ovarian cancer gain extra months with addition of drug to standard chemotherapy
Saturday, March 28, 2015 - 11:00
in Health & Medicine
Overall survival for women who received standard chemotherapy treatment plus bevacizumab was a median five months longer than for women who received the standard chemotherapy treatment alone.